Back to search results

Treatment of Patients With Progressive mCRPC With 177Lu-PSMA-617

Abroad (travel likely)RecruitingPHASE2

Conditions

Metastatic Castration-Resistant Prostate Cancer · Prostate Cancer Patients With Bone Metastasis · Prostate Cancer (CRPC) · Prostate Cancer · Prostate Cancer Metastatic

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Excel Diagnostics & Nuclear Oncology Center, Houston, Texas, United States

    Contact: Study coordinator (Susan Cork Therapy Coordinator) · scork@exceldiagnostics.com · 713-781-6200
    Contact: Study coordinator (Nereyda Sauceda, Therapy Coordinator) · nsauceda@exceldiagnostics.com · 713-781-6200
    Contact: Principal Investigator (Ebrahim S. Delpassand, M.D. Chairman & Medical Director, MD.Nuclear Medicine)
Study leads

  • Ebrahim S. Delpassand, M.D. Chairman & Medical Director, MD., Nuclear Medicine

    Principal Investigator

    Excel Diagnostics & Nuclear Oncology Center

View source on ClinicalTrials.gov(opens in a new tab)